Osidge said:
One of the main findings of the work that Sid brought to the attention of the Forum is that more research is needed. I would hope that we could all agree that such research would increase our knowledge so that we can make the best decisions about managing our diabetes.
It'll probably be the case when the costs of the genetics is further reduced. Great progress is being made. Just over a decade ago the cost of squencing an entire human genome was just over $1,000,000. today it is around the $10,000 mark. It is expected to fall as low as $100 in the next ten years.
The Wellcome Trust Case Control Consortium is comprises 50 research groups accross the UK and aims were to exploit progress in understanding of patterns of human genome sequence variation along with advances in high-throughput genotyping technologies, and to explore the utility, design and analyses of genome-wide association (GWA) studies. It has substantially increased the number of genes known to play a role in the development of some of our most common diseases and has to date identified approximately 90 new variants across all of the diseases analysed. As well as confirming many of the known associations, some 28 in total, the WTCCC has also identified many novel variants that affect susceptibility to disease.
Studies concerned with diabetes are headed by:
Type 1 Diabetes
David Clayton, JDRF/WT Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research
John Todd, University of Cambridge
Type 2 Diabetes
Andrew Hattersley, Diabetes and Vascular Medicine, Peninsula Medical School
Mark McCarthy, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
Some publications I have found in the list include:
Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach.
Perry et al, 2009
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Z
eggini et al 2008
Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.
Nejentsev et al, 2007
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.
Todd et al, 2007
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
Zeggini et al, 2007
"What has been achieved in this research is the analysis of half a million genetic variants in each of seventeen thousand individuals, with the discovery of more than ten genes that predispose to common diseases."
"Amongst the most significant new findings are four chromosome regions containing genes that can predispose to type 1 diabetes and three new genes for Crohn's disease (a type of inflammatory bowel disease). For the first time, the researchers have found a gene linking these two autoimmune diseases, known as PTPN2."
"The pathways that lead to Crohn's disease are increasingly well understood and we hope that progress in treating Crohn's disease may give us clues on how to treat type 1 diabetes in the future"
Research from the Consortium had already played a major part in identifying the clearest genetic link yet to obesity and three new genes linked to type 2 diabetes, published in April in advance of the main study. It has found independently a major gene region on chromosome 9 identified by independent studies on coronary heart disease.
I think this last bit refers to the KLF14 gene discussed here by McCarthy:
Genetic ‘master switch’ identified in obesity and diabetes
http://www.ox.ac.uk/media/news_stories/2011/111605.html
The paper:
http://www.ncbi.nlm.nih.gov/pmc/article ... -35276.pdf